Brain SPECT guided repetitive transcranial magnetic stimulation (rTMS) in treatment resistant major depressive disorder

Asian Journal of Psychiatry

Volumn 21, Issue , 2016, Pages 1-6

  Jha, Shailesh ^a   Chadda, Rakesh K ^b   Kumar, Nand ^b   Bal, C S ^b  

^a INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Brain SPECT; Outcome; RTMS; Treatment resistant depression

Indexed keywords

ADULT; ARTICLE; BRAIN PERFUSION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DORSOSLATERAL PREFRONTAL CORTEX; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR DEPRESSION; MALE; NEUROIMAGING; OUTCOME ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STIMULUS RESPONSE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ADULT; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREFRONTAL CORTEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84959365776     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2016.02.003     Document Type: Article

References (37)

1. Baeken C., Vanderhasselt M-A., Remue J., Herremans S., Vanderbruggen N., Zeeuws D., Santermans L., De Raedt R. Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients. J. Affect. Disord. 2013, 151:625-631.
2. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
3. Bench C.J., Frackowiak R.S., Dolan R.J. Changes in regional cerebral blood flow on recovery from depression. Psychol. Med. 1995, 25:247-261.
4. Berlim M.T., McGirr A., Beaulieu M., Turecki G. High frequency repetitive transcranial magnetic stimulation as an augmenting strategy in severe treatment-resistant major depression: a prospective 4-week naturalistic trial. J. Affect. Disord. 2011, 130:312-317.
5. Berlim M.T., van den Eynde F., Tovar-Perdomo S., Daskalakis Z.J. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol. Med. 2014, 44:225-239.
6. Chen J., Zhou C., Wu B., Wang Y., Li Q., Wei Y., Yang D., et al. Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials. Psychiatry Res. 2013, 210:1260-1264.
7. Chen J., Liu Z., Zhu D., Li Q., Zhang H., Huang H., et al. Bilateral vs. unilateral repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomized controlled trials: a review article. Psychiatry Res. 2014, 219:51-57.
8. Ciobanu C., Girard M., Marin B., Labrunie A., Malauzat D. rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age. J. Affect. Disord. 2013, 150:677-681.
9. Daskalakis Z.J., Levinson A.J., Fitzgerald P.B. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can. J. Psychiatry 2008, 53:555-566.
10. Downar J., Daskalakis Z.J. New targets for rTMS in depression: a review of convergent evidence. Brain Stimul. 2013, 6:231-240.
11. Fava M. Diagnosis and definition of treatment-resistant depression. Biol. Psychiatry 2003, 53:649-659.
12. Fitzgerald P.B., Hoy K.E., Herring S.E., McQueen S., Peachey A.V., Segrave R.A., Maller J., Hall P., Daskalakis Z.J. A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression. J. Affect. Disord. 2012, 139:193-198.
13. Ganguli M., Ratcliff G., Chandra V., Sharma S., Gilby J.E., Pandav R., Belle S., Ryan C.M., Baker C.R., Seaberg C.R., DeKosky S.T. A Hindi version of the MMSE: the development of a cognitive screening instrument for a largely illiterate rural elderly population in India. Int. J. Geriatr. Psychiatry 1995, 10:367-377.
14. Garcia-Toro M., Salva J., Daumal J., Andres J., Romera M., Lafau O., Echevarría M., et al. High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression. Psychiatry Res. 2006, 146:53-57.
15. George M.S., Lisanby S.H., Avery D., McDonald W.M., Durkalski V., et al. Daily Left Prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham controlled randomized trial. Arch. Gen. Psychiatry 2010, 67:507-516.
16. Guy W. ECDEU Assessment Manual for Psychopharmacology 1976, 76-338. U.S. Department of Health, Education, and Welfare, Rockville, MD, DHEW Publication No. (ADM).
17. Hadley D., Anderson B.S., Borckardt J., Arana A., Li X., Nahas Z., George M.S. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J. ECT 2011, 27:18-25.
18. Herwig U., Padberg F., Unger J., Spitzer M., Schonfeldt-Lecuona C. Transcranial magnetic stimulation in therapy studies: examination of the reliability of standard coil positioning by neuronavigation. Biol. Psychiatry 2001, 50:58-61.
19. Holtzheimer P.E., Russo J., Avery D. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol. Bull. 2001, 35:149-169.
20. Kennedy S.H., Javanmard M., Vaccarino F.J. A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Can. J. Psychiatry 1997, 42:467-475.
21. Kessler R.C., Berglund P., Demler O. The epidemiology of major depressive disorder: results from the National Co morbidity Survey Replication (NCS-R). J. Am. Med. Assoc. 2003, 289:3095-3105.
22. Kimbrell T.A., Little J.T., Dunn R.T., Frye M.A., Greenberg B.D., Wassermann E.M., Repella J.D., Danielson A.L., Willis M.W., Benson B.E., Speer A.M., Osuch E., George M.S., Post R.M. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol. Psychiatry 1999, 46:1603-1613.
23. Kito S., Fujita K., Koga Y. Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression. J. Neuropsychiatry Clin. Neurosci. 2008, 20:74-80.
24. Kozel F.A., George M.S. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J. Psychiatr. Pract. 2002, 8:270-275.
25. Lam R.W., Chan P., Wilkins-Ho M., Yatham L.N. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. Can. J. Psychiatry 2008, 53:621-631.
26. Lefaucheur J-P., André-Obadia N., Antal A., Ayache S.S., Baeken C., Benninger D.H., Cantello R.M., Cincotta M., de Carvalho M., De Ridder D., Devanne H., Di Lazzaro V., Filipović S.R., Hummel F.C., Jääskeläinen S.K., Kimiskidis V.K., Koch G., Langguth B., Nyffeler T., Oliviero A., et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin. Neurophysiol. 2014, 125(11):2150-2206.
27. Li C.T., Wang S.J., Hirvonen J., Hsieh J.C., Bai Y.M., Hong C.J., Liou Y.J., Su T.P. Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. J. Affect. Disord. 2010, 127:219-229.
28. McHorney C.A., Ware J.E., Reczek A.E. The MOS 36-item Short-Form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health construct. Med. Care 1993, 31:247-263.
29. Montgomery S.A., Åsberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
30. O'Reardon J.P., Amsterdam J.D. Treatment-resistant depression: progress and limitations. Psychiatr. Ann. 1998, 28:633-640.
31. O'Reardon J.P., Solvason H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., McDonald W.M., Avery D., Fitzgerald P.B., Loo C., Demitrack M.A., George M.S., Sackeim H.A. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol. Psychiatry 2007, 62:1208-1216.
32. Paillère Martinot M.L., Galinowski A., Ringuenet D., Gallarda T., Lefaucheur J.P., Bellivier F. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. Int. J. Neuropsychopharmacol. 2010, 13:45-59.
33. Richieri R., Boyer L., Farisse J., Colavolpe C., Mundler O., Lançon C., Guedj E. Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression. Eur. J. Nucl. Med. Mol. Imaging 2011, 38:1715-1722.
34. Rigucci S., Serafini G., Pompili M., Kotzalidis G.D., Tatarelli R. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. World J. Biol. Psychiatry 2010, 11:165-180.
35. Rush A.J., Thase M.E., Dube S. Research issues in the study of difficult-to-treat depression. Biol. Psychiatry 2003, 53:743-753.
36. Thase M.E., Rush A.J. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J. Clin. Psychiatry 1997, 58(Suppl. 13):23-29.
37. Weiduschat N., Dubin M.J. Prefrontal cortical blood flow predicts response of depression to rTMS. J. Affect. Disord. 2013, 150:699-702.